VIS-832

N/A

Report date: 2022/10/25 17:50:29

Base Information

Drug NameVIS-832
Drug Alias NameVIS-832
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-CD138Wnt signalling pathway inhibitors
TargetsSyndecan-1
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVisterra Inc
China Registration ClassN/A

Develop Information

Active CompaniesVisterra Inc
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A